87
Collaborate with us

31 January 2025

As part of a recent collaboration which arouse from one of opnMe’s Molecule for collaboration projects, we had the chance to speak to Carla Castellar Álvarez, scientific manager at Nanomol Technologies in Spain. The company specializes in delivering advanced solutions to obtain high-added value products by particle design and nanoformulation1.

32
Collaborate with us

27 January 2025

The reciprocal interaction between the intestinal tract and the liver, the gut-liver axis, is known to play a crucial role in maintaining hepatic homeostasis and function. Perturbation of this bidirectional crosstalk through an impaired intestinal barrier is observed in chronic liver disease and involves inflammation and tissue remodeling.

62
Discover us

18 December 2024

Don’t miss the chance to connect with other scientists and researchers in the life science community at Boehringer Ingelheim’s Transforming Science Day at the European Molecular Biology Laboratory (EMBL) campus in Heidelberg on February 25, 2025.

43
Discover us

06 January 2025

Are you prepared to elevate your career to new heights? We invite you to join us in Innsbruck, a place where cutting-edge innovation harmoniously coexists with the breathtaking beauty of the Austrian Alps. Our state-of-the-art facilities at ViraTherapeutics, coupled with a dynamic work culture, make Innsbruck an ideal location for both professional growth and personal enrichment.

36
Discover us

11 December 2024

We are glad to announce that the entire collection of high-quality molecules offered for free on opnMe.com is also now part of the open access collection of Compounds Australia. Through Compounds Australia, all opnMe molecules can now be accessed in flexible assay-ready formats by drug discovery researchers across Australia and around the world.

Discover us

Hear from our collaborators

slide 1 to 2 of 13